Latest Articles
Daniella Karagach Compares Robert Irwin to This Previous “DWTS” Contestant Who 'Won Everyone's Hearts' (Exclusive) - Yahoo News Canada
Daniella Karagach Compares Robert Irwin to This Previous “DWTS” Contestant Who 'Won Everyone's Hearts' (Exclusive) Yahoo News Canada
Published: June 3, 2025, 9:14 p.m.
Daniella Karagach Compares Robert Irwin to This Previous “DWTS” Contestant Who 'Won Everyone's Hearts' (Exclusive) - Yahoo
Daniella Karagach Compares Robert Irwin to This Previous “DWTS” Contestant Who 'Won Everyone's Hearts' (Exclusive) Yahoo
Published: June 3, 2025, 9:14 p.m.
Health Me Episode 4: Menopause expert Dr Caoimhe Hartley focuses on the complexities of women's midlife health - EVOKE
Health Me Episode 4: Menopause expert Dr Caoimhe Hartley focuses on the complexities of women's midlife health EVOKE
Published: June 3, 2025, 8:32 a.m.
Health Me Episode 4: Menopause expert Dr Caoimhe Hartley focuses on the complexities of women's midlife health - evoke.ie
Health Me Episode 4: Menopause expert Dr Caoimhe Hartley focuses on the complexities of women's midlife health evoke.ie
Published: June 3, 2025, 8:32 a.m.
From period pain to heart disease, the gender health gap is real — here’s how to close it - Down To Earth
From period pain to heart disease, the gender health gap is real — here’s how to close it Down To Earth
Published: June 3, 2025, 6:12 a.m.
CNN Faces Changes as Veteran Correspondent Departs - Men's Journal
CNN Faces Changes as Veteran Correspondent Departs Men's Journal
Published: June 3, 2025, 1:22 a.m.
How One Startup Is Aiming to Replace Surgery with Its Endometriosis Diagnostic - MedCity News
How One Startup Is Aiming to Replace Surgery with Its Endometriosis Diagnostic MedCity News
Published: June 3, 2025, 1:19 a.m.
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial - BioSpace
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial BioSpace
Published: June 2, 2025, 11:48 p.m.
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) - GuruFocus
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) GuruFocus
Published: June 2, 2025, 7:05 p.m.
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial - GlobeNewswire
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial GlobeNewswire
Published: June 2, 2025, 6:32 p.m.
Link copied to clipboard!